日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lunar farside volcanism 2.8 billion years ago from Chang'e-6 basalts

28亿年前月球背面嫦娥六号玄武岩火山活动

Zhang, Qian W L; Yang, Mu-Han; Li, Qiu-Li; Liu, Yu; Yue, Zong-Yu; Zhou, Qin; Chen, Liu-Yang; Ma, Hong-Xia; Yang, Sai-Hong; Tang, Xu; Zhang, Guang-Liang; Ren, Xin; Li, Xian-Hua

Identifying clustering in patterns of late effects among survivors of adolescent and young adult Hodgkin lymphoma

识别青少年和青年霍奇金淋巴瘤幸存者远期效应模式的聚集性

Parker, Kellee; Heneghan, Mallorie B; Li, Qian W; Brunson, Ann; Ou, Judy; Kaddas, Heydon K; Abrahão, Renata; Chubak, Jessica; Wernli, Karen J; Zebrack, Brad; Hahn, Erin E; Kushi, Lawrence H; Nichols, Hazel B; Keegan, Theresa; Kirchhoff, Anne C

Identifying Patterns of Late Effects With Latent Class Analysis Among Adolescent and Young Adult Thyroid Cancer Survivors in California and Utah

利用潜在类别分析识别加利福尼亚州和犹他州青少年及青年甲状腺癌幸存者的远期效应模式

Ou, Judy Y; Keegan, Theresa; Li, Qian W; Kaddas, Heydon K; Abrahão, Renata; Brunson, Ann; Sauder, Candice A M; Chubak, Jessica; Kushi, Lawrence H; Hahn, Erin E; Chao, Chun; Nichols, Hazel B; Kirchhoff, Anne C

[Paying more attention to burn induced coagulopathy]

【更加关注烧伤引起的凝血功能障碍】

Luo, G X; Zhang, Q R; Qian, W; Li, H S

[Efficacy and safety of fourth-generation CD19 CAR-T expressing IL7 and CCL19 along with PD-1 monoclonal antibody for relapsed or refractory large B-cell lymphoma]

【表达IL7和CCL19的第四代CD19 CAR-T细胞联合PD-1单克隆抗体治疗复发或难治性大B细胞淋巴瘤的疗效和安全性】

Yu, T; Liu, H; Lei, W; Chen, P P; Zhao, A Q; Yuan, X G; Gao, J M; Qian, W B

[Efficacy and safety analysis of the zanubrutinib-based bridging regimen in chimeric antigen receptor T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma]

[基于泽布替尼的桥接方案在嵌合抗原受体T细胞疗法治疗复发/难治性弥漫性大B细胞淋巴瘤中的疗效和安全性分析]

Lu, Y; Liu, H; Ye, S G; Zhou, L L; Luo, X; Dang, X Y; Yuan, X G; Qian, W B; Liang, A B; Li, P

[Characteristics and impact factors of SARS-CoV-2 infection in adult patients with relapsed/refractory B-cell non-Hodgkin lymphoma receiving chimeric antigen receptor T-cell therapy]

[接受嵌合抗原受体T细胞疗法的复发/难治性B细胞非霍奇金淋巴瘤成人患者SARS-CoV-2感染的特征和影响因素]

Ge, T; Liu, H; Wang, Z H; Cao, Y; Zhang, Y C; Huang, L; Qian, W B; Zhou, X X

Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors

HIV 感染者和未感染者霍奇金淋巴瘤幸存者治疗后发生第二原发性恶性肿瘤的风险

Abrahão, Renata; Brunson, Ann M; Kahn, Justine M; Li, Qian W; Wun, Ted; Keegan, Theresa H M

[How I manage B cell lymphoma patients treated with CD19 specific CAR-T cell throughout whole-process management]

[我如何管理接受 CD19 特异性 CAR-T 细胞治疗的 B 细胞淋巴瘤患者的全过程]

Qian, W B; Liu, H

[Clinical characteristics and prognosis of patients with aggressive NK cell leukemia]

【侵袭性NK细胞白血病患者的临床特征和预后】

Qian, W S; Shen, L; Wulipan, Fulati; Wu, M; Ma, J X; Chen, P P; Xu, Y; Xie, Y H